EXELON CORP — Director's Dealing 2018

Jan 19, 2018

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2017-12-31

Reporting Person: Von Hoene William A. Jr. (Sr. Executive Vice President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	113550	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit Awards	$0		Common Stock (59139)	59139	Direct
Restricted Stock Unit Grant 10/21/2013	$0		Common Stock (20000)	20000	Direct
Deferred Compensation Equivalent Shares	$0		Common Stock (3330)	3330	Direct
NQ Stock Option 03/12/2012	$39.81		Common Stock (88000)	88000	Direct
NQ Stock Option 01/24/2011	$43.4		Common Stock (67000)	67000	Direct
NQ Stock Option 01/25/2010	$46.09		Common Stock (33000)	33000	Direct
NQ Stock Option 01/26/2009	$56.51		Common Stock (25200)	25200	Direct
NQ Stock Option 01/28/2008	$73.29		Common Stock (19000)	19000	Direct

Footnotes

F1: Balance includes the following shares acquired through dividend reinvestment: 1,001, 993, 963 and 905 shares acquired on March 10, 2017, June 9, 2017, September 8, 2017 and December 9, 2017 respectively.

F2: Restricted stock unit awards made pursuant to the Exelon Long Term Incentive Plan. Share awards are made annually in January at the Compensation and Leadership Development committee's meeting and vest in 1/3 increments on the date of the committee's January meeting in the first, second and third years after the award was made.

F3: Balance consists of unvested shares remaining from the awards granted in January of the previous three years along with shares acquired through automatic dividend reinvestment as follows: 520, 516, 499 and 468 shares acquired on March 10, 2017, June 9, 2017, September 8, 2017 and December 9, 2017 respectively.

F4: Restricted stock grant made pursuant to the Exelon Long Term Incentive Plan. 100% of the shares will vest on October 21, 2018.

F5: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition.

F6: Balance inlcudes 30, 32, 33 and 25 share equivalents accrued on February 13, 2017, May 11, 2017, August 11, 2017 and November 14, 2017 respectively thorugh automatic dividend reinvestment.

F7: Non qualified employee stock options, awarded pursuant to the Exelon Long Term Incentive Plan. Options vest in 1/4 increments on each of the first four anniversaries of the grant date, referenced in column one, and expire on the tenth anniversay of the grant date.